Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Lobular × Goserelin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 118 Breast Neoplasms 80 Neoplasms 6 Breast Neoplasms, Male 6 Neoplasm Metastasis 4 Salivary Gland Neoplasms 3 Prostate Adenocarcinoma 3 Advanced Breast Cancer 3 Recurrence 2 Osteoporosis 2 Leiomyoma 2 Infertility 2 Advanced Prostate Cancer 2 Triple Negative Breast Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Sexual Dysfunction, Physiological 1 Radiation Injuries 1 Primary Ovarian Insufficiency 1 Primary Dysautonomias 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Osteitis Deformans 1 Myofibroma 1 Lymphatic Metastasis 1 Kidney Diseases 1 Inflammatory Breast Neoplasms 1 Hypertension 1 Hyperlipidemias 1 Hot Flashes 1 Hormone-sensitive Metastatic Breast Cancer 1

Interventions

Letrozole 6 Radiotherapy 4 atamestane 3 Toremifene 3 Magnetic Resonance Spectroscopy 3 Chemotherapy, Adjuvant 3 Trastuzumab 2 Tamoxifen 2 Fulvestrant 2 Estrogen Receptor Modulators 2 Docetaxel 2 Cyclophosphamide 2 Carboplatin 2 Capecitabine 2 Aromatase Inhibitors 2 repotrectinib 1 proto-oncogene protein c-fes-fps 1 palbociclib 1 neratinib 1 gallium 68 PSMA-11 1 fluciclovine F-18 1 entrectinib 1 Zolpidem 1 Vinorelbine 1 Venlafaxine Hydrochloride 1 Thiotepa 1 Sugars 1 Radiotherapy, Conformal 1 Radiation 1 Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04551495 2024-12-04

ROSALINE

Jules Bordet Institute

Phase 2 Active not recruiting

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡